Mandate

Vinge advisor to the lead investors in connection with Kry’s USD 300m financing round

The financing round was led by CPP Investments (CPPIB) and Fidelity Management & Research Company LLC with participation from existing investors, including the Ontario Teachers’ Pension Plan, Index Ventures, Accel, Creandum and Project A.

Vinge has acted as lead counsel to the lead investors CPP Investments (CPPIB) and Fidelity Management & Research Company LLC in connection with the financing round.

 

Kry will use the investment to scale its platform, building on both its operations as a healthcare provider and its innovative software offerings as well as further geographic expansion. This will bring the benefits of its technology to millions more patients across Europe. Kry, which has been growing rapidly since it was founded in 2015, has helped over three million patients access healthcare to date.

 

The company grew over 100% year-on-year in 2020 in response to supporting patients and healthcare systems across Europe during the pandemic. The new funding will help the company meet the increasing patient demand for their virtual healthcare services and fulfil its vision of making high-quality healthcare accessible for all.

 

Vinge’s team included partners Johan Larsson and Matthias Pannier, together with Karl Klackenberg, Michaela Cronemyr and Carl Fredrik Wachtmeister (M&A), Mathilda Persson and Karl-Hugo Engdahl (IT & Data Protection) and Sara Strandberg (Employment).  

Related

Vinge advises Calliditas Therapeutics in connection with Asahi Kasei Corporation’s public takeover offer

On 28 May 2024, Asahi Kasei Corporation announced a public takeover offer to the shareholders and holders of American Depositary Shares in Calliditas Therapeutics AB (publ) (”Calliditas Therapeutics”) to acquire all shares and American Depositary Shares (each representing two shares) in Calliditas Therapeutics.
May 28, 2024

Vinge has advised Alder on the establishment of Alder III

Vinge has advised Alder on the establishment of Alder's third and largest fund to date, Alder III.
May 27, 2024